|Brand name(s), other common name(s)||Blenoxane®|
|Drug type||Antitumor antibiotic|
|How the drug is given||Intravenously (IV) or by intramuscular (IM)|
or subcutaneous (SC) injection
Bleomycin is FDA approved as a single agent or in proven combinations to treat people who have Hodgkin and non-Hodgkin lymphoma. Bleomycin may cause a temporary loss of hair in some people. Normal hair growth should return after treatment ends (although it may take several months).
Side effects needing medical attention:Cough; shortness of breath.